Literature DB >> 25142628

Completeness of pedigree and family cancer history for ovarian cancer patients.

Yedong Son1, Myong Cheol Lim2, Sang Soo Seo1, Sokbom Kang1, Sang Yoon Park3.   

Abstract

OBJECTIVE: To investigate the completeness of pedigree and of number of pedigree analysis to know the acceptable familial history in Korean women with ovarian cancer.
METHODS: Interview was conducted in 50 ovarian cancer patients for obtaining familial history three times over the 6 weeks. The completeness of pedigree is estimated in terms of familial history of disease (cancer), health status (health living, disease and death), and onset age of disease and death.
RESULTS: The completion of pedigree was 79.3, 85.1, and 85.6% at the 1st, 2nd, and 3rd time of interview and the time for pedigree analysis was 34.3, 10.8, and 3.1 minutes, respectively. The factors limiting pedigree analysis were as follows: out of contact with their relatives (38%), no living ancestors who know the family history (34%), dispersed family member because of the Korean War (16%), unknown cause of death (12%), reluctance to ask medical history of relatives (10%), and concealing their ovarian cancer (10%). The percentage of cancers revealed in 1st (2%) and 2nd degree (8%) relatives were increasing through surveys, especially colorectal cancer related with Lynch syndrome (4%).
CONCLUSION: Analysis of pedigree at least two times is acceptable in Korean woman with ovarian cancer from the first study. The completion of pedigree is increasing, while time to take family history is decreasing during three time survey.

Entities:  

Keywords:  Completeness; Family history; Lynch syndrome; Ovarian cancer; Pedigree

Mesh:

Year:  2014        PMID: 25142628      PMCID: PMC4195306          DOI: 10.3802/jgo.2014.25.4.342

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  32 in total

Review 1.  Reconsidering the family history in primary care.

Authors:  Eugene C Rich; Wylie Burke; Caryl J Heaton; Susanne Haga; Linda Pinsky; M Priscilla Short; Louise Acheson
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

2.  Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.

Authors:  A M Martin; M A Blackwood; D Antin-Ozerkis; H A Shih; K Calzone; T A Colligon; S Seal; N Collins; M R Stratton; B L Weber; K L Nathanson
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

3.  Genograms. Practical tools for family physicians.

Authors:  I Waters; W Watson; W Wetzel
Journal:  Can Fam Physician       Date:  1994-02       Impact factor: 3.275

4.  Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer.

Authors:  Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Moon-Woo Seong; Bo-Yon Lee; Sang-Yoon Park
Journal:  Jpn J Clin Oncol       Date:  2010-10-21       Impact factor: 3.019

5.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

Review 6.  Familial ovarian cancer.

Authors:  L Elit
Journal:  Can Fam Physician       Date:  2001-04       Impact factor: 3.275

7.  A comparison of positive family history definitions for defining risk of future disease.

Authors:  S C Hunt; R R Williams; G K Barlow
Journal:  J Chronic Dis       Date:  1986

8.  BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Authors:  Myong Cheol Lim; Sokbom Kang; Sang-Soo Seo; Sun-Young Kong; Bo-Yon Lee; Seon-Kyung Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-05       Impact factor: 4.553

9.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

10.  Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Hong Gwan Seo; Jin-Soo Lee
Journal:  Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.679

View more
  5 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).

Authors:  Min Chul Choi; Myong Cheol Lim; Dong Hoon Suh; Yong Jung Song; Tae Joong Kim; Suk Joon Chang; Jae Weon Kim
Journal:  J Gynecol Oncol       Date:  2016-03-30       Impact factor: 4.401

3.  Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.

Authors:  Qianying Zhao; Jiaxin Yang; Lei Li; Dongyan Cao; Mei Yu; Keng Shen
Journal:  J Gynecol Oncol       Date:  2017-07       Impact factor: 4.401

4.  Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.

Authors:  Anne-Sophie Sandner; Ramona Weggel; Yasmin Mehraein; Stephanie Schneider; Wolfgang Hiddemann; Karsten Spiekermann
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

5.  Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics.

Authors:  Qianlan Yao; Yanhui Liu; Lihua Zhang; Lin Dong; Longlong Bao; Qianming Bai; Qian Cui; Jie Xu; Min Li; Jing Liu; Shannon Chuai; Jianming Ying; Zhihong Zhang; Xiaoyan Zhou
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.